| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
| Sales | 3,484 | 4,304 | 3,586 | 6,063 | 7,185 |
| Sales Growth | -19.04% | +20.02% | -40.85% | -15.62% | +6.46% |
| Net Income | -3,930 | -7,246 | -3,979 | -799 | -960 |
| Net Income Growth | +45.76% | -82.10% | -398.00% | +16.77% | +14.67% |
Jayex Technology Ltd (JTL.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Jayex Technology Ltd is a company operating in the healthcare industry. The company is engaged in developing and providing service technologies for the healthcare industry and also in developing integrated dispensing automation systems for the pharmaceutical and healthcare sectors. Jayex Technology provides healthcare systems that help manage appointments and communicate patient information effectively. The company's main products and services consist of healthcare industry service technologies. Jayex Technology operates in two segments, namely Australia and the United Kingdom, with the majority of its revenue generated in the United Kingdom.
Fiscal Year End Date: 12/31